Robot takes aim: new device could make prostate cancer biopsies more accurate and less painful

NCT ID NCT07271017

Summary

This study is testing a new robotic device called ProBot to see if it is safe and practical for performing prostate biopsies. The device is designed to be more precise and potentially cause less discomfort during the procedure, which is used to diagnose prostate cancer. Researchers will enroll 60 men at high risk for prostate cancer to see how well the robot-assisted biopsy works compared to standard methods.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (DIAGNOSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins Hospital

    RECRUITING

    Baltimore, Maryland, 21287, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.